The objective of the study is to evaluate the effect of iguratimod concomitant with
conventional immunosuppressive drugs on preventing antibody-induced rejection in HLA Highly
mismatched Kidney Transplant recipients.
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University